Dissemin is shutting down on January 1st, 2025

Published in

BioMed Central, Cancer Cell International, 1(22), 2022

DOI: 10.1186/s12935-022-02662-3

Links

Tools

Export citation

Search in Google Scholar

Three-dimensional (3D) cell culture: a valuable step in advancing treatments for human hepatocellular carcinoma

Journal article published in 2022 by Asmaa F. Khafaga ORCID, Shaker A. Mousa, Lotfi Aleya, Mohamed M. Abdel-Daim ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

AbstractHepatocellular carcinoma (HCC) is the fifth most common malignant cancer and the third most frequent cause of tumour-related mortality worldwide. Currently, several surgical and medical therapeutic strategies are available for HCCs; however, the interaction between neoplastic cells and non-neoplastic stromal cells within the tumour microenvironment (TME) results in strong therapeutic resistance of HCCs to conventional treatment. Therefore, the development of novel treatments is urgently needed to improve the survival of patients with HCC. The first step in developing efficient chemotherapeutic drugs is the establishment of an appropriate system for studying complex tumour culture and microenvironment interactions. Three-dimensional (3D) culture model might be a crucial bridge between in vivo and in vitro due to its ability to mimic the naturally complicated in vivo TME compared to conventional two-dimensional (2D) cultures. In this review, we shed light on various established 3D culture models of HCC and their role in the investigation of tumour-TME interactions and HCC-related therapeutic resistance. Graphical Abstract